Moneycontrol PRO
Loans
HomeNewsBusinessMarketsSell-off in banks, IT drags Nifty below 9K; Sensex see-saws 1,400 pts from day's high, ends at 36-month low
Live now
auto refresh

Sell-off in banks, IT drags Nifty below 9K; Sensex see-saws 1,400 pts from day's high, ends at 36-month low

The Sensex ended 810.98 points down at 30,579.09, while Nifty shed 230.70 points at 8,966.70.

March 17, 2020 / 17:07 IST
  • Moneycontrol.com
  • IndexPricesChangeChange%
    Sensex82,181.86391.74 +0.48%
    Nifty 5025,186.90109.25 +0.44%
    Nifty Bank56,410.25305.40 +0.54%
    Nifty 50 25,186.90 109.25 (0.44%)
    Tue, Oct 07, 2025
    Biggest GainerPricesChangeChange%
    Jio Financial312.306.05 +1.98%
    Biggest LoserPricesChangeChange%
    Trent4,690.00-87.30 -1.83%
    Best SectorPricesChangeChange%
    Nifty Infra9169.1053.25 +0.58%
    Worst SectorPricesChangeChange%
    Nifty PSU Bank7600.60-14.55 -0.19%


  • March 17, 2020 / 17:07 IST

    Rupee Closing

    The Indian rupee ended at 74.25 against the US dollar, rising 2 paise compared to Monday's close of 74.27 a dollar.

  • March 17, 2020 / 16:42 IST

    Amit Shah, Technical Research Analyst with Indiabulls Securities:

    8,550 zone is important on the downside and a breach of the mentioned support will add further pressure on the downside. On the way up 9,400 is likely to act as resistance zone. We continue with our advice of avoiding any bottom fishing in such kind of scenario.

  • March 17, 2020 / 16:20 IST

    Rohit Singre, Senior Technical Analyst at LKP Securities:

    On monthly chart index has good support near 8500 zone and 100 DMA is also place at 8435 zone hinting any break below said levels can create some more pressure in indices, resistance for index is coming near 9150-9300 zone. Traders can use said levels to create fresh short near these levels.

  • March 17, 2020 / 16:15 IST

    Vinod Nair, Head of Research at Geojit Financial Services:

    After trading in the positive for the majority of the day, the indices turned red during the last hour of trading, with selling mainly seen in Financials. European markets and Dow futures added to the negativity. Covid-19 showed no signs of abatement and with Central Banks monetary policy actions having limited impact, calls were out for more actions to contain the spread of the virus.

  • March 17, 2020 / 16:05 IST

    Pankaj Bobade, Head- Fundamental Research, Axis Securities:

    It is difficult to protect equity portfolios in these volatile times and retail investor should hold on to their portfolios without throwing in their prized silver to the volatilities and risk aversion. Instead of getting carried away by the risk aversion, the retail investor should look at it as an opportunity by the market, to buy and select good quality companies/ stocks at reasonable valuations, if one has an investment horizon of more than 2 years. It is difficult to time the market, hence one should stagger their purchases and hold on to it through the rough ride.

  • March 17, 2020 / 15:32 IST

    Market Close:

    Benchmark indices ended lower for the second consecutive session on March 17 with Nifty closed below the psychological level of 9000.

    At close, the Sensex was down 810.98 points or 2.58% at 30,579.09, and the Nifty was down 230.70 points or 2.51% at 8,966.70. About 765 shares have advanced, 1624 shares declined, and 152 shares are unchanged.

    Yes Bank, Eicher Motors, HUL, Maruti Suzuki and Hero MotoCorp were among major gainers on the Nifty, while losers include Zee Entertainment, ICICI Bank, IndusInd Bank, Bharti Infratel and UPL.

    Among sectors except FMCG and Pharma, all other indices ended in the red. BSE Midcap and Smallcap indices shed 1-2 percent.

  • March 17, 2020 / 15:26 IST

    Indian Hume bags 2 orders

    The company has received two work orders from Public Health Engineering Department (PHED), Jaipur, Rajasthan worth Rs 355 crore. The projects is to be completed within 30 months.

  • March 17, 2020 / 15:14 IST

    Dr Reddy's launches Ziprasidone Mesylate in US market

    Dr. Reddy's Laboratories launched Ziprasidone Mesylate for Injection, 20 mg (base)/ml Single-dose Vials, the therapeutic generic equivalent of Geodon Injection, 20 mg/ml, approved by the US Food and Drug Administration (USFDA).

  • March 17, 2020 / 15:12 IST

    Dow Futures erased all the gains and slipped over 900 points from the day's high.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347